ARGENT

Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies

Coordinatore	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE    more  Organization address address: Rue Michel -Ange 3 city: PARIS postcode: 75794 contact info Titolo: Ms. Nome: Véronique Cognome: Debisschop Email: send email Telefono: +33 1 69823272 Fax: +33 1 69823333
Nazionalità Coordinatore	France [FR]
Totale costo	3˙656˙454 €
EC contributo	3˙656˙454 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2013-ITN
Funding Scheme	MC-ITN
Anno di inizio	2014
Periodo (anno-mese-giorno)	2014-03-01   -   2018-02-28

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE  Organization address address: Rue Michel -Ange 3 city: PARIS postcode: 75794 contact info Titolo: Ms. Nome: Véronique Cognome: Debisschop Email: send email Telefono: +33 1 69823272 Fax: +33 1 69823333	FR (PARIS)	coordinator	683˙525.84
2	AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS  Organization address address: CALLE SERRANO 117 city: MADRID postcode: 28006 contact info Titolo: Ms. Nome: María ángeles Cognome: López Vázquez Email: send email Telefono: 34915681462 Fax: 34915681573	ES (MADRID)	participant	739˙806.38
3	THE OPEN UNIVERSITY  Organization address address: WALTON HALL city: MILTON KEYNES postcode: MK7 6AA contact info Titolo: Dr. Nome: Louise Cognome: Thomas Email: send email Telefono: +44 1908 858509 Fax: +44 1908654192	UK (MILTON KEYNES)	participant	608˙797.62
4	QUEEN'S UNIVERSITY BELFAST  Organization address address: University Road city: BELFAST postcode: BT7 1NN contact info Titolo: Mrs. Nome: Colleen Cognome: Spence Email: send email Telefono: +44 28 9097 5183 Fax: +44 28 9097 5182	UK (BELFAST)	participant	483˙863.03
5	CHEMATECH SAS  Organization address address: RUE DU BAS DE CHANOT 7 city: CHEVIGNY SAINT SAUVEUR postcode: 21800 contact info Titolo: Dr. Nome: Frédéric Cognome: Boschetti Email: send email Telefono: 33380396110 Fax: +33 3 80 39 61 17	FR (CHEVIGNY SAINT SAUVEUR)	participant	255˙948.66
6	COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES  Organization address address: RUE LEBLANC 25 city: PARIS 15 postcode: 75015 contact info Titolo: Mr. Nome: Jean-Christophe Cognome: Coste Email: send email Telefono: 33169089097 Fax: 33169082199	FR (PARIS 15)	participant	255˙948.66
7	NANOH SAS  Organization address address: PLACE DE L'EUROPE 2, PARC D'ACTIVITES GVIO 2, BAT A city: SAINT QUENTIN FALLAVIER postcode: 38070 contact info Titolo: Dr. Nome: Cedric Cognome: Louis Email: send email Telefono: +33 6 9916 8784	FR (SAINT QUENTIN FALLAVIER)	participant	255˙948.66
8	GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH  Organization address address: PLANCKSTRASSE 1 city: DARMSTADT postcode: 64291 contact info Titolo: Ms. Nome: Heike Cognome: Kühlen Email: send email Telefono: 496160000000 Fax: 496160000000	DE (DARMSTADT)	participant	253˙454.74
9	QuantumWise A/S  Organization address address: LERSO PARKALLE 107 city: Copenhagen postcode: 2100 contact info Titolo: Mrs. Nome: Nanna Cognome: Fock Email: send email Telefono: +45 69901888 Fax: +45 69802801	DK (Copenhagen)	participant	119˙160.41
10	JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN  Organization address address: GRUNEBURGPLATZ 1 city: FRANKFURT AM MAIN postcode: 60323 contact info Titolo: Prof. Nome: Andrey Cognome: Solov'yov Email: send email Telefono: +49 6979847507	DE (FRANKFURT AM MAIN)	participant	0.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

Cancer, the second most common form of death after cardiovascular disease, is a major European health concern. In 2006, 3.1 million new cases were diagnosed and 1.7 million deaths were attributed to cancer within Europe. The European Commission has a “European Partnership for Action against Cancer” (IP/09/1380) with the aim of reducing the number of cancer cases by 15% by 2020. A key challenge is to “Develop a more coordinated approach to cancer-related research across Europe”. Around 50% of patients receive radiotherapy as part of their cancer treatment and it is second only to surgery in its ability to cure cancer. However, radiotherapy is limited by the effects induced in the surrounding healthy tissues strongly, which very harmful for the patients. New approaches that enhance radiosensitivity within tumours have the potential to provide a major impact on the delivery of radiotherapy to patients. Two of the most promising approaches (hadron and nanoparticles-enhanced therapies) are driven by nanoscale phenomena. This proposal brings together world-leading researchers from the academic and private sectors aim at developing hadron and NP-enhanced therapies, united by the common purpose of optimising radiotherapy by understanding and exploiting nanoscale processes induced by radiation. Such an understanding will open a new era in which radiotherapy is revolutionised to provide more successful cancer treatment with subsequent economic and ‘quality of life’ benefits for the EU population as a whole. The main objective of this intersectoral and multidisciplinary ITN is to create a new generation of researchers and experts able to create the platform on which next-generation cancer therapy will be built. The consortium aims to train a cohort of 13 ESRs to subsequently act as leaders and ambassadors in the field.